Overview

A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease

Status:
RECRUITING
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
This is an open, multi-center clinical study designed to evaluate the efficacy and safety of TQ05105 Tablets in patients with chronic graft-versus-host disease
Phase:
PHASE2
Details
Lead Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.